CLINICAL TRIALS PROFILE FOR CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
✉ Email this page to a colleague
All Clinical Trials for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | Diabetes Australia | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | Hoffmann-La Roche | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | National Health and Medical Research Council, Australia | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | Baker Heart Research Institute | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00279617 ↗ | Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks | Completed | UCB Pharma | Phase 3 | 2006-01-01 | The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder. |
| NCT00279617 ↗ | Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks | Completed | University of Cincinnati | Phase 3 | 2006-01-01 | The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Condition Name
Condition MeSH
Clinical Trial Locations for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Trials by Country
Clinical Trial Progress for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Sponsor Name
| Sponsor Name for CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | |
| Sponsor | Trials |
| Innogene Kalbiotech Pte. Ltd | 5 |
| Yuria-Pharm | 4 |
| Institut d'Anesthesiologie des Alpes Maritimes | 3 |
| [disabled in preview] | 7 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
